U.S. Global AIDS Coordinator discusses lessons learned from U.S. response to HIV/AIDS worldwide

NewsGuard 100/100 Score

U.S. Global AIDS Coordinator Ambassador Eric Goosby "discussed lessons learned from the U.S. response to the global HIV/AIDS epidemic over the past decade at an event hosted by the Brookings Institute Monday morning," the Center for Global Health Policy's "Science Speaks" blog reports. "While calling recent scientific advances in HIV prevention 'game changers' that have offered hope of an AIDS-free generation, [Goosby said] that the successful fight against the epidemic relies on recognizing AIDS-specific efforts so far as a foundation for further health gains, on country ownership, and on continuing to build 'the shared responsibility' of a multi-donor response," the blog adds. 

Goosby "highlighted the accomplishments of PEPFAR in the last 10 years saying that while a decade ago almost no one in Africa had access to lifesaving antiretroviral medicine, over 6.6 million people are getting lifesaving treatment thanks to PEPFAR and multilateral donors like the Global Fund to Fight AIDS, TB, and Malaria, with the U.S. directly supporting treatment for 3.9 million people worldwide," "Science Speaks" writes (Aziz, 6/25). "Goosby defended PEPFAR as a key ingredient for success in stemming the pandemic and making country health systems stronger overall," Devex states, adding, "Goosby also emphasized the need for greater country ownership in delivering health services" in order to achieve sustainability (Brookland, 6/26). According to GlobalPost's "Global Pulse" blog, Goosby "said that the Obama administration was on target for meeting goals for putting people on treatment, reducing the number of babies infected with HIV, and expanding male circumcisions -- but he acknowledged that the circumcision effort was tough going" (Donnelly, 6/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk